Post tick-borne encephalitis virus vaccination narcolepsy with cataplexy

Sleep

Volumn 39, Issue 10, 2016, Pages 1811-1814

  Hidalgo, Hildegard ^a   Kallweit, Ulf ^a,b   Mathis, Johannes ^b   Bassetti, Claudio L ^b  

^a Clinic Katzenelnbogen   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cataplexy; Dendritic cells; Granzyme; Hypocretin; Narcolepsy; Tick borne encephalitis virus vaccination

Indexed keywords

HLA DQB1 ANTIGEN; TICK BORNE ENCEPHALITIS VACCINE; INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CASE STUDY; CATAPLEXY; CEREBROSPINAL FLUID; CHILD; DAYTIME SOMNOLENCE; EOSINOPHILIA; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPNAGOGIC HALLUCINATION; LIMIT OF DETECTION; MALE; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; NEUROLOGIC EXAMINATION; NIGHTMARE; PARASOMNIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SWEATING; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS VIRUS; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VITAMIN D DEFICIENCY; WEIGHT GAIN; YOUNG ADULT; ADVERSE EFFECTS; ENCEPHALITIS, TICK-BORNE; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; GERMANY; RISK FACTOR;

ADOLESCENT; ADULT; CATAPLEXY; CHILD; DATABASES, FACTUAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; INFLUENZA VACCINES; MALE; NARCOLEPSY; RETROSPECTIVE STUDIES; RISK FACTORS; VACCINATION; YOUNG ADULT;

EID: 84992315732     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.6160     Document Type: Article

References (21)

1. Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015; 14:318-28.
2. Tafti M, Hor H, Dauvilliers, et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014; 37:19-25.
3. Orellana C, Villemin E, Tafti M, Carlander B, Besset A, Billiard M. Stressful life events in the year preceding the onset of narcolepsy. Sleep 1994; 17:S50-3.
4. Aran A, Lin L, Nevismalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009; 32:979-83.
5. Han F, Warby SC, Faraco J, Li J, Dong SX, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70:410-7.
6. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012; 7:e33536.
7. Vaarala O, Vuorela A, Partinen M, et al. Antigenic differences between AS03 Adjuvanted Influenza A (H1N1) pandemic vaccines: implications for Pandemrix-associated narcolepsy Risk. PLoS One 2014; 9:e114361.
8. Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015; 47:44-57.
9. Schöndorf I, Beran J, Cizkova D, et al. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 2007; 25:1470-5.
10. Robert Koch Institut: Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health. FSME: Risikogebiete in Deutschland (Stand: Mai 2015). Epidemiologisches Bulletin 2015; 21:175-90.
11. Heininger U. Schutz vor FSME - Update 2015. ARS MEDICI 2014; 24:1251-3.
12. Robert Koch Institut: Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health. Mitteilung der Ständigen Impfkommission am Robert Koch-Institut (RKI) - Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: August 2014. Epidemiologisches Bulletin 25. August 2014 / Nr. 34.
13. Bundesamt für Gesundheit (BAG), Schweizerische Kommission für Impffragen (SKIF): Zeckenenzephalitis: Empfehlungen zur Impfung gegen Zeckenenzephalitis. Bull BAG 2006; Nr. 13:225-231.
14. Robert-Koch-Institute, Germany: http://www.pei.de/DE/arzneimittelsicherheit-vigilanz/pharmakovigilanz/uaw-datenbank/uaw-datenbank-node.html.
15. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsycataplexy. Sleep 2010; 33:1428-30.
16. Pizza F, Peltola H, Sarkanen T, Moghadam KK, Plazzi G, Partinen M. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. Sleep Med 2014; 15:262-5.
17. Marth E, Kleinhappl B, Jelovcan S. Stimulation of the immune system by different TBE-virus vaccines. Int J Med Microbiol 2004; 293:139-44.
18. Koller A, Doser K, Hartmann K, Fleisch F, Kuhn M. Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrungen der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ). Prax is 2002; 91:159-62.
19. Fabricius D, Nußbaum B, Busch D, et al. Antiviral vaccines license T cell responses by suppressing granzyme B levels in human plasmacytoid dendritic cells. J Immunol 2013; 191:1144-53.
20. Wensink AC, Hack CE, Bovenschen N. Granzymes regulate proinflammatory cytokine responses. J Immunol 2015; 194:491-7.
21. Ahmed SS, Volkmuth W, Duca J, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015; 7:294ra105.